Characteristics | Trial period | |
---|---|---|
Intervention | Control | |
Live births, N | 3,725 | 3,905 |
Mortality for births <1000 g | ||
Births <1000 g, N | 10 | 7 |
Neonatal deaths, N | 9 | 7 |
Neonatal mortality < 28 days, n (rate/1000) | 900 | 1000 |
Mortality for births 1000–1499 g | ||
Births 1000–1499 g, N | 22 | 20 |
Neonatal deaths, N | 14 | 10 |
Neonatal mortality < 28 days, n (rate/1000) | 636 | 500 |
Mortality rates for births 1500–2499 g | ||
Births 1500–2499 g, N | 487 | 454 |
Neonatal deaths, N | 20 | 33 |
Neonatal mortality < 28 days, n (rate/1000) | 41.1 | 72.7 |
Mortality rates for births ≥ 2500 g | ||
Births ≥ 2500 g, N | 3,206 | 3,424 |
Neonatal deaths, N | 38 | 52 |
Neonatal mortality < 28 days, n (rate/1000) | 11.9 | 15.2 |